ciprofloxacin has been researched along with Tuberculosis, Drug-Resistant in 34 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report three patients who experienced hepatotoxic reactions in association with acetaminophen ingestion while undergoing treatment for active tuberculosis with isoniazid, rifampin, and other agents." | 7.69 | Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. ( Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE, 1994) |
| "In the present study, sensitivity and specificity of the phage assay when compared to proportion method were in the range of 97 to 100 per cent for all the drugs except for ciprofloxacin for which it was 93 and 96 per cent, respectively." | 3.78 | In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates. ( Chitnis, DS; Hemvani, N; Patidar, V, 2012) |
| "We report three patients who experienced hepatotoxic reactions in association with acetaminophen ingestion while undergoing treatment for active tuberculosis with isoniazid, rifampin, and other agents." | 3.69 | Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. ( Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE, 1994) |
| "All ciprofloxacin DST results were susceptible by both methods." | 1.56 | MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia. ( Balada-Llasat, JM; Evans, CA; Gelaw, B; Kelley, HV; Shibabaw, A; Tesfaye, E; Tessema, B; Torrelles, JB; Wang, SH, 2020) |
| " We aim to compare the culture conversion between new-generation (levofloxacin and moxifloxacin) and old-generation (ciprofloxacin and ofloxacin) fluoroquinolones, develop pharmacokinetic models, and calculate target attainment for levofloxacin and moxifloxacin." | 1.51 | Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection. ( Ahmed, S; Al-Shaer, MH; Alghamdi, WA; Alkabab, Y; Alsultan, A; An, G; Banu, S; Barbakadze, K; Cegielski, JP; Heysell, SK; Houpt, E; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA, 2019) |
| "We report a chronic case of pulmonary tuberculosis in a Malagasy citizen from Antsohihy (West of Madagascar), who was infected with a multi-drug resistant Mycobacterium bovis strain." | 1.32 | [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar]. ( Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V, 2003) |
| "Ciprofloxacin was used primarily to treat Mycobacterium avium complex (MAC) infection, dosed to achieve 2-hour post-dose serum concentrations of 4-6 micrograms/ml." | 1.29 | Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections. ( Berning, SE; Iseman, MD; Madsen, L; Peloquin, CA, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (29.41) | 18.2507 |
| 2000's | 7 (20.59) | 29.6817 |
| 2010's | 16 (47.06) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Vavříková, E | 1 |
| Polanc, S | 1 |
| Kočevar, M | 1 |
| Horváti, K | 2 |
| Bosze, S | 2 |
| Stolaříková, J | 2 |
| Vávrová, K | 1 |
| Vinšová, J | 2 |
| Baranyai, Z | 1 |
| Krátký, M | 1 |
| Szabó, N | 1 |
| Senoner, Z | 1 |
| Dávid, S | 1 |
| Zhang, T | 1 |
| Shen, W | 1 |
| Liu, M | 1 |
| Zhang, R | 1 |
| Wang, M | 1 |
| Li, L | 1 |
| Wang, B | 1 |
| Guo, H | 1 |
| Lu, Y | 1 |
| Krasavin, M | 1 |
| Lukin, A | 1 |
| Vedekhina, T | 1 |
| Manicheva, O | 1 |
| Dogonadze, M | 1 |
| Vinogradova, T | 1 |
| Zabolotnykh, N | 1 |
| Rogacheva, E | 1 |
| Kraeva, L | 1 |
| Yablonsky, P | 1 |
| Shibabaw, A | 1 |
| Gelaw, B | 1 |
| Kelley, HV | 1 |
| Tesfaye, E | 1 |
| Balada-Llasat, JM | 1 |
| Evans, CA | 2 |
| Torrelles, JB | 1 |
| Wang, SH | 1 |
| Tessema, B | 1 |
| Yang, Y | 1 |
| Niehaus, KE | 1 |
| Walker, TM | 1 |
| Iqbal, Z | 1 |
| Walker, AS | 1 |
| Wilson, DJ | 1 |
| Peto, TEA | 1 |
| Crook, DW | 1 |
| Smith, EG | 1 |
| Zhu, T | 1 |
| Clifton, DA | 1 |
| de Oliveira, LP | 1 |
| Carneiro, ZA | 1 |
| Ribeiro, CM | 1 |
| Lima, MF | 1 |
| Paixão, DA | 1 |
| Pivatto, M | 1 |
| de Souza, MVN | 1 |
| Teixeira, LR | 1 |
| Lopes, CD | 1 |
| de Albuquerque, S | 1 |
| Pavan, FR | 1 |
| Guerra, W | 1 |
| Yılmaz, FF | 1 |
| Eraç, B | 1 |
| Ermertcan, Ş | 1 |
| Çavuşoğlu, C | 1 |
| Biçmen, C | 1 |
| Aktoğu Özkan, S | 1 |
| Hoşgör Limoncu, M | 1 |
| Cilliers, P | 1 |
| Seldon, R | 1 |
| Smit, FJ | 1 |
| Aucamp, J | 1 |
| Jordaan, A | 1 |
| Warner, DF | 1 |
| N'Da, DD | 1 |
| Al-Shaer, MH | 1 |
| Alghamdi, WA | 1 |
| Alsultan, A | 1 |
| An, G | 1 |
| Ahmed, S | 1 |
| Alkabab, Y | 1 |
| Banu, S | 1 |
| Barbakadze, K | 1 |
| Houpt, E | 1 |
| Kipiani, M | 1 |
| Mikiashvili, L | 1 |
| Cegielski, JP | 1 |
| Kempker, RR | 1 |
| Heysell, SK | 1 |
| Peloquin, CA | 3 |
| Ziganshina, LE | 3 |
| Titarenko, AF | 1 |
| Davies, GR | 1 |
| Farhat, MR | 1 |
| Mitnick, CD | 1 |
| Franke, MF | 1 |
| Kaur, D | 1 |
| Sloutsky, A | 1 |
| Murray, M | 1 |
| Jacobson, KR | 1 |
| Li, W | 1 |
| Obregón-Henao, A | 1 |
| Wallach, JB | 1 |
| North, EJ | 1 |
| Lee, RE | 1 |
| Gonzalez-Juarrero, M | 1 |
| Schnappinger, D | 1 |
| Jackson, M | 1 |
| Hemvani, N | 2 |
| Patidar, V | 2 |
| Chitnis, DS | 2 |
| Toit, K | 1 |
| Mitchell, S | 1 |
| Balabanova, Y | 1 |
| Kummik, T | 1 |
| Nikolayevskyy, V | 1 |
| Drobniewski, F | 1 |
| Ruh, E | 1 |
| Ocal, HY | 1 |
| Yurdakul, P | 1 |
| Sarıbaş, Z | 1 |
| Alp, A | 1 |
| Norra, C | 1 |
| Skobel, E | 1 |
| Breuer, C | 1 |
| Haase, G | 1 |
| Hanrath, P | 1 |
| Hoff, P | 1 |
| Huang, TS | 1 |
| Lee, SS | 1 |
| Tu, HZ | 1 |
| Huang, WK | 1 |
| Chen, YS | 1 |
| Huang, CK | 1 |
| Wann, SR | 1 |
| Lin, HH | 1 |
| Liu, YC | 1 |
| Ramarokoto, H | 1 |
| Andrianasolo, D | 1 |
| Rasolonavalona, T | 1 |
| Ramaroson, F | 1 |
| Razafitsiarovana, I | 1 |
| Vincent, V | 1 |
| Ratsimba, L | 1 |
| Rasolofo Razanamparany, V | 1 |
| Vizel, AA | 1 |
| Squire, SB | 2 |
| Nolan, CM | 2 |
| Sandblom, RE | 1 |
| Thummel, KE | 1 |
| Slattery, JT | 1 |
| Nelson, SD | 1 |
| Stevens, JP | 2 |
| Daniel, TM | 2 |
| Berning, SE | 2 |
| Madsen, L | 1 |
| Iseman, MD | 1 |
| Passannante, MR | 1 |
| Gallagher, CT | 1 |
| Reichman, LB | 1 |
| Fisher, M | 1 |
| Tomlinson, DR | 1 |
| Coker, RJ | 1 |
| Yew, WW | 2 |
| Chau, CH | 2 |
| Gach, O | 1 |
| Corhay, JL | 1 |
| Lousberg, L | 1 |
| Bartsch, P | 1 |
| Grimaldo, ER | 1 |
| Tupasi, TE | 1 |
| Rivera, AB | 1 |
| Quelapio, MI | 1 |
| Cardaño, RC | 1 |
| Derilo, JO | 1 |
| Belen, VA | 1 |
4 reviews available for ciprofloxacin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Topics: Antitubercular Agents; Ciprofloxacin; Drug Substitution; Fluoroquinolones; Humans; Levofloxacin; Ofl | 2013 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized | 2005 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized | 2008 |
Multidrug-resistant tuberculosis in the USA: the end of the beginning.
Topics: Antitubercular Agents; BCG Vaccine; Ciprofloxacin; Health Personnel; Humans; Pyrazinamide; Tuberculo | 1996 |
30 other studies available for ciprofloxacin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
New fluorine-containing hydrazones active against MDR-tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Fluorine; Humans; Hydrazones; Microbial Sensitivity Tests | 2011 |
Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Topics: Anti-Bacterial Agents; Carbamates; Cell Line; Dose-Response Relationship, Drug; Esters; Humans; Micr | 2015 |
Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus; Fluoroquinolones; Microbial S | 2015 |
Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Imida | 2018 |
MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Ciprofloxacin; Culture Media; Ethiopia; Extensively Drug-R | 2020 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sen | 2018 |
Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicity and evaluation against drug-resistant tuberculosis.
Topics: Cell Line, Tumor; Cell Survival; Ciprofloxacin; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor | 2018 |
In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity | 2018 |
Design, synthesis, and antimycobacterial activity of novel ciprofloxacin derivatives.
Topics: Animals; Antitubercular Agents; CHO Cells; Ciprofloxacin; Cricetulus; HEK293 Cells; Humans; Mycobact | 2019 |
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ciprofloxacin; Dose-Response Rela | 2019 |
Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Microbial Sensitivity Tes | 2015 |
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Topics: Animals; Antitubercular Agents; Bacterial Load; Bacterial Proteins; Biological Transport; Ciprofloxa | 2016 |
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Iso | 2012 |
The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains.
Topics: Antitubercular Agents; Ciprofloxacin; Color; Drug Resistance, Multiple, Bacterial; Estonia; Extensiv | 2012 |
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensi | 2012 |
[Evaluation of Tetrazolium Violet and Resazurin Assays for Ciprofloxacin Susceptibility Testing of Resistant Mycobacterium tuberculosis Isolates].
Topics: Antitubercular Agents; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosi | 2013 |
Ciprofloxacin-induced acute psychosis in a patient with multidrug-resistant tuberculosis.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; | 2003 |
Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Ethionamide; Humans; Microbial Sen | 2004 |
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; | 2003 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Fema | 1994 |
Chemoprophylaxis of multidrug-resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide. A decision analysis.
Topics: Adult; Ciprofloxacin; Decision Support Techniques; Decision Trees; Health Personnel; HIV Seronegativ | 1995 |
Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Middle Age | 1995 |
Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey.
Topics: Adult; Antitubercular Agents; Ciprofloxacin; Delphi Technique; Humans; Middle Aged; Pyrazinamide; Tu | 1994 |
Bacille Calmette Guérin immunization of health care workers exposed to multidrug-resistant tuberculosis: a decision analysis.
Topics: Antitubercular Agents; BCG Vaccine; Ciprofloxacin; Decision Support Techniques; Health Personnel; Hu | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitu | 1996 |
Advice on treatment of drug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Ciprofloxacin; Cycloserine; Drug Monitoring; Drug Resistance, Microbia | 1997 |
Fluoroquinolones and tuberculosis.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tubercul | 1998 |
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis].
Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breas | 1999 |
Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Drug Resistance, Mu | 2001 |
Utility of fluoroquinolones in multidrug-resistant tuberculosis (MDR-TB)--a balanced view?
Topics: Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Microbial Sensiti | 2002 |